Enrique A. Conterno - 06 Jan 2023 Form 4 Insider Report for FIBROGEN INC (FGEN)

Role
Chief Executive Officer, Director
Signature
/s/ Cecelia Monoarfa-Taime, Attorney-in-fact
Issuer symbol
FGEN
Transactions as of
06 Jan 2023
Net transactions value
-$30,683
Form type
4
Filing time
10 Jan 2023, 15:46:14 UTC
Previous filing
09 Dec 2022
Next filing
23 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FGEN Common Stock Sale $30,683 -1,538 -0.52% $19.95* 295,483 06 Jan 2023 Direct F1, F2
holding FGEN Common Stock 27,800 06 Jan 2023 By Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.
F2 Includes one share acquired on November 15, 2022 through the Issuer's Employee Stock Purchase Plan.